Increased mean corpuscular volume of erythrocytes with capecitabine treatment in metastatic breast cancer patients: A marker of clinical benefit?


Aksoy S., Arslan C., Kurt M., Dizdar O., Dede D. S., Dogan E., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.28, sa.15, 2010 (SCI-Expanded) identifier